Eton Pharmaceuticals, Inc
Price
FilingsNewest: 8-K, Other eventsSep 28 →InsidersNo open-market buys. 3 insiders sold $8.7M, 0 of 8 sales on a 10b5-1 plan.→HoldersOpaleye 10.1%Nantahala 8.3%EcoR1 Capital 7.7%→PeersClosest companies: DERM, XFOR, XERS→
From the filings
Figures
- Revenue
- $105.6Mlast 12 months
- Net income
- $12.7Mlast 12 months
- Operating cash flow
- $15.8Mlast 12 months
- Cash and equivalents
- $26.8Mat the last balance sheet
- Total debt
- $27.9Mat the last balance sheet
- Shares outstanding
- 28.3M shareson issue